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Abstract Biological systems such as bacteria, fungi or plants for synthesis of noble
nanoparticles (NPs) are easy, inexpensive and eco-friendly. Obtained bioparticles
due to its physico-chemical nature possess biologically active properties such as
antimicrobial activity. In this study, the biological synthesis of silver (Ag) and gold
(Au) nanoparticles using Streptomyces sp. strain NH21 isolated from acidic soil and
its antibacterial activity against bacteria is presented. The physico-chemical prop-
erties of obtained particles were characterized. UV–Vis showed broad peak at 404
and 424 nm for AgNPs and 564 nm for AuNPs. Transmission electron microscopy
studies showed small sized nanoparticles of 44 nm for supernatant and 8.4 nm for
biomass synthesized AgNPs, and 10 nm for supernatant synthesized AuNPs, which
was confirmed by nanoparticle tracking analyses. Fourier transform infrared spec-
troscopy revealed the presence of capping agents over metal-NPs. The negative Zeta
potential values of metal-NPs indicated stability of biosynthesized particles. In vitro
antibacterial activity and minimal inhibitory concentration of NPs was assessed
against Gram-positive and Gram-negative bacteria. Unlike to gold-NPs, silver-NPs
showed reliable antibacterial activity. Atomic force microscopy analysis recorded
changes in cell morphology of tested bacterial strains after treatment with
nanoparticles.
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Introduction
The rise of antibiotic-resistance in pathogenic microorganisms represents one of the
most serious problems facing humankind. Antibiotic resistance is rapidly depleting
the limited range of antibiotic therapies which has led to a call from academics and
clinicians that action needs to be taken to replace the current generation of
antibiotics. There is a real risk in the near future that there will be few or no
antibiotic for drug resistant microorganisms, particularly multidrug resistant (MDR)
Gram-negative pathogens [1]. Consequently, developing new or better antibiotics
and non-antibiotic compounds will have a clear and positive impact on global public
health.
Nanotechnology provides an excellence platform to modify and develop the
properties of metals by converting them into their nanoform (nanoparticles) which
has applications in numerous fields like diagnostic, drug delivery, antimicrobial
agents and treatment of various diseases [2]. Several physical and chemical methods
have been developed to produce silver and gold nanoparticles. Synthetic techniques
based on the reduction of metal ions with sodium citrate or sodium borohydride,
followed by surface modification of the produced particles with suitable capping
ligands and organic solvent raised environmental concerns because of the toxic
compounds used in the process. Synthetic methods results in mixed-shape of
nanoparticles (NPs) that require expensive and low-yield purification procedure.
These limitations invite new eco-friendly methodology for production of nanocrys-
tals with desired shape. Biosynthesis method have emerged as a simple, non-toxic
and environmental friendly. The nanoparticles synthesis by living organism came
with several challenges such a reducing the time of synthesis and better
understanding of their size and shape.
Biological resources available in nature including plants, fungi, yeast, actino-
mycetes and bacteria can be employed for synthesis of NPs, including silver and
gold nanoparticles, which exhibited different biological activity [3–9].
Nevertheless, the number of prokaryotic organisms (bacteria and actinomycetes)
have been evaluated for their ability to produce NPs, the synthesis is limited and
needs to be extended. Although actinomycetes are well exploited for antibiotics and
other high value metabolites, they are less studied in terms of nanoparticles. Free
amine groups and cysteine residues of the actinomycete proteins bind to silver or
gold NPs and stabilize synthesized nanoparticles. Proteins involved in reduction of
silver or chloroauric ions and cap the metal NPs may belong to the enzymes
released from cells. Different proteins may occur as a capping and stabilizing agent
on the surface of metal nanoparticles [10, 11].
Actinomycetes secret four specific proteins of molecular masses between 10 and
80 kDa. The nature of different proteins and their strength of interaction may vary
with different nanorystals which may lead to the formation of complex morphology
and size [11].
Various biological agents react differently with metal ions leading to the
formation of nanoparticles. Many microorganisms produce metal nanoparticles
either intra– or extra cellularly. In case of actinomycetes, the reduction of metal ions
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take place on the surface of mycelia along with cytoplasmatic membrane resulting
in the formation of nanoparticles [12].
The intracellular method of metal nanoparticle synthesis involves special ion
transportation in the microbial cell. The cell wall of microorganism plays an
important role. The mechanism involves electrostatic interaction of the positive
charge metal ions with negatively charged cell wall. Mechanism of synthesis of
silver nanoparticles by microorganism is found to be nitrate reductase mediated
[13].
The enzymes involved in gold synthesis are not exactly known. Recently,
involvement of phenol oxidase in this process have been reported [14].
Antimicrobial potential of metal nanoparticles have been evaluated against a
wide range of bacterial, including MDR and fungal pathogens [15, 16]. The unusual
physiochemical properties of nanoparticles are attributed to their small size
(\10 nm), surface structure, reactive groups and coatings [17]. AgNPs are one of
the most widely used nanoparticles and notably serving as an antimicrobial agent for
medical applications [18–22].
The antimicrobial toxicity of AgNPs may be explained by their interaction with
microbes involving silver ion release and particle cellular internalization [23], also
they have emerged as novel agents because of their high surface area to volume
ratio and the unique chemical and physical properties. AgNPs interact with many
compounds of bacterial cell: (1) peptidoglycan of cell wall, (2) cytoplasmatic
membrane, where chemical and physical properties are modified causing change in
osmolality, permeability and electron transport, (3) ribosomal DNA, molecular sites
of phosphorus and sulfur present in proteins [24]. Compared with other metals silver
exhibits higher toxicity to microorganism while lower toxicity to mammalian cells
[25]. AgNPs preferable attack the respiratory chain, cell division and finally leading
to cell death [19]. Gold nanoparticles, in general, are preferred over other inorganic
nanoparticles for biomedical applications due to its excellent biocompatibility with
human cells. However, the toxicity caused by AuNPs is a great topic of debate due
to the ambiguity in the studies undertaken to determine its harmful effects. Some
studies reported non-toxic whereas others toxic effect of AuNPs to human cells [26].
Because of stability of oxidation resistance and biocompatibility gold nanopar-
ticles found wide application in electronics, catalysis, chemical testing and imaging,
drug delivery and biological labeling [27]. Biocompatible AuNPs were found to be
efficient agent in cancer therapy [28]. Williams et al. [29] reported that AuNPs used
alone did not show antibacterial activity. However, AuNPs conjugated with
antibiotics were found to improve antibiotic activity and delivery. The improvement
efficacy of antibacterial antibiotics conjugated with AuNPs was evaluated against
various bacterial strains [30].




The Streptomyces sp. NH21 strain was isolated from humic layer of acidic pine
forest soil. The sample site was located on north slope of inland dune in
Czerniewice forest district (525503700N, 184201100E) near Torun, Poland. The
humic layer, approximately 2 cm wide, contained an amorphous mass of
decomposed needles, humic material and other organic matter. The mean pH value
of soil was estimated at 3.65 (±1.2). The strain was maintained on Starch Casein
Agar slopes (SCA, K}uster and Williams, 1964 [31]) at 27 C and as a spore
suspension in 20 % glycerol (v/v) at -80 C.
Identification of Streptomyces sp. NH21 Strain
Biomass for the molecular systematic study was prepared by cultivating the isolate
in shake flask of yeast extract-malt extract broth (pH 5.5) at 150 revolutions per
minute at 27 C for 2 weeks. Cells were harvested by centrifugation and washed
three times with sterile distilled water. Genomic DNA was extracted from cells
using a GenEluteTM Bacterial Genomic Kit (Sigma), according to the instructions of
the manufacturer, previously treated with lysozyme at 45 mg mL-1 and incubated
overnight at 37 C. The 16S rRNA was amplified by using universal primers p27f
and p1525r [32]. PCR-mediated amplification of the 16 S rRNA gene of the isolate
were carried out as described by Golinska et al. [33]. The PCR product was purified
with GenEluateTM PCR Clean-Up Kit (Sigma) and sent to Institute of Biochemistry
and Biophysics Polish Academy of Sciences for sequencing. The closest phyloge-
netic neighbors based on 16S rRNA gene similarities were found using the EzTaxon
server [34]. The phylogenetic analysis were performed according to methods
described previously by Golinska et al. [33].
Biosynthesis of Nanoparticles Using Supernatant and Biomass
of Actinobacteria Culture
Actinobacterial Streptomyces sp. NH21 strain was inoculated in flask with ISP2
broth and incubated in rotary shaker at 27 C for 14 days. After incubation strain
was centrifuged 60009g for 15 min at 4 C. The cell free supernatant was collected
and combined with 3 mM silver nitrate (AgNO3) for silver nanoparticles synthesis
or 3 mM chloroauric acid (HAuCl4) for gold nanoparticles synthesis, both 1:1 (v/v).
The mixture was kept in shaker (130 rev/min, 27 C) in darkness up to 72 h. The
biomass obtained from centrifugation was washed three times with sterile distillated
water, then suspended in water and kept for next 48 h for starvation. The biomass
was then centrifuged 60009g for 15 min. The supernatant was filtered by sterile
0.22 lm filter, challenged with relevant reagent (AgNO3 or HAuCl4) and incubated,
as described previously. During the incubation period flasks were observed for color
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change from yellow to dark-brown for AgNPs and from yellow to purple for AuNPs
formation.
Silver and Gold Nanoparticles Analyses
UV–Visible Spectroscopy Studies
The presence of synthesized nanostructures were confirmed by UV–Vis spec-
troscopy analysis using spectrophotometer (NanoDrop 2000, Thermo Scientific,
USA) at wavelength range of 200–700 nm.
Transmission Electron Microscopy (TEM) Studies
TEM analysis of silver and gold nanoparticles were carried out using FEI Europe
TEM microscope, model Tecnai F20 X-Twin at 100 kV coupled with the energy
dispersive X-ray (EDX), selected area electron diffraction pattern (SAED) and fast
Fourier transform (FFT) analysis (XFlash 4010 Bruker AXS). The sample
containing dried nanoparticles was diluted in sterile double distilled water, applied
on carbon-coated cooper TEM grids (400 lm mesh size) and dried in room
temperature. The acquired data were evaluated by Statistica Software (StatSoft,
USA) using the variability plot of average methods.
XRD Spectroscopy Analysis
The fingerprint characterization of crystalline metallic silver and gold nanoparticles
and the determination of their structure were performed by X-ray analysis
diffraction (XRD). The AgNPs sample (powder) was deposited into the sample
holder and pressed to get a smooth plane surface. The diffraction pattern was
recorded over a 2h range of 5–120 by X-ray diffractometer (X’Pert Pro Analytical
Phillips, Lelyweg, Netherlands) equipped with Ni filter and CuKa (k = 1.54056 A˚)
radiation source. The obtained diffractogram was compared to the standard database
of the International Centre for Diffraction Data (ICDD).
Fourier Transform Infrared (FT-IR) Spectroscopy Studies
The characterization of functional groups on the surface of AgNPs and AuNPs was
investigated by FT-IR spectrometer Spectrum 2000 (Perkin-Elmer). The sample was
prepared by dispersing the nanoparticles in a matrix of dry KBr compressed to form
a disc. The spectrum was scanned in the range of 4000–500 cm-1 at a resolution of
4 cm-1.
NTA Studies
The size and distribution of size of synthesized nanoparticles were measured using
nanoparticle tracking analysis (NTA) system by NanoSight Ltd., (Amesbury, UK).
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Samples were diluted in 5 lL of nuclease-free water and injected into the chamber.
The size of nanoparticles was then measured.
Zeta Potential Analysis
The zeta potential was measured to determine the stability of silver and gold
nanoparticles using the Zetasizer Nano ZS 90 (Malvern Instrument Ltd., UK). 25 lL
of nanoparticle samples were diluted 10 times with water and sonicated for 15 min
at 20 Hz. Then mixture was filtered with of 0.22 lm filter and used for zeta
potential measurement. The dilution of AgNPs or AuNPs were carried out to avoid
the aggregation of nanoparticles. Measurements were obtained in the range of -200
to ?200 mV.
Determination of Minimal Inhibitory Concentration (MIC) and Minimal
Bactericidal Concentration (MBC) of Silver and Gold Nanoparticles
The MIC and MBC studies of biosynthesized nanoparticles against pathogenic
organisms such as Salmonella infantis (strain obtained from Sanitary-Epidemio-
logical Station in Torun, Poland) Proteus mirabilis (strain obtained from the
collection of the Collegium Medicum, Nicolaus Copernicus University in Poland),
Bacillus subtilis (ATTC6633), Staphylococcus aureus (ATTC6338), Klebsiella
pneumoniae (ATTC700603), Pseudomonas aeruginosa (ATTC10145) and Escher-
ichia coli (ATTC8739). Studies were performed in the 96 microtiter plates. The
synthesized AgNPs and AuNPs were screened for MIC by microtiter broth dilution
method in triplicates. Trypticase soy broth (TSB) was used as diluents for bacterial
strains. The final concentration of bacterial cells in each well was 1 9 106 CFU/mL,
and various concentrations (1.25–200 lg/mL) of AgNPs or AuNPs were used. The
positive and negative controls were also maintained. After incubation for 24 h at
37 C the microtiter plates were read at 450 nm using BIOLOG multimode reader
after incubation to determine the minimum inhibitory concentration values. The
MIC is expressed as the lowest concentration of compound, which inhibited the
bacterial growth when compared with control. Moreover, the minimum bactericidal
concentrations (MBC) expressed as the lowest concentration of nanoparticles that
kills C90 % of bacterial cells were estimated.
Atomic Force Microscopy (AFM)
The alterations in the bacterial cell surface caused by silver or gold nanoparticles
were confirmed by Agilent 5500 atomic force microscopy (Keysight Technologies).
Ten microliters of suspension containing bacterial cells with nanoparticles cultured
in TSB medium were applied on a gelatin-coated glass surface [35]. The samples
were incubated for the 20 min in room temperature, gently rinsed with deionized
water and nitrogen dried before imaging. Sample were imaged in contact mode in
air, using MLCT silicon nitride cantilevers with a spring constant of 0,01 N/m and a
nominal tip apex radius of 20 nm. Topography and deflection images were obtained
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at a scan rate 0,5 ln/s at a resolution of 512 pixel per line. The data were analyzed
with Gwyddion 2.41 software [36].
Data Analysis
Antibacterial activity data were analyzed by using t test (for AgNPs concentration
10 lg/mL) and Kruskal–Wallis One Way Analysis of Variance on ranks (for AgNPs
concentration 5 lg/mL). In all analyses, a probability level of P\ 0.05 was used for
the significance of differences between values. The obtained data were evaluated by
Statistica Software (StatSoft, USA).
Results
Identification of Actinobacteria Strain
Near complete 16S rRNA gene sequence (1406 nucleotides [nt]) of the isolate
Streptomyces sp. NH21 was determined. Strain NH21 was found to be loosely
associated with the type strain of Streptomyces yanglinesis 1307T in the neighbour-
joining tree though this relationship were supported by 97 % bootstrap value and by
all of the tree-making methods. The two strains shared 99.2 % 16S rRNA gene
sequence similarity, a value which corresponded to 11 nt differences at 1404
locations. Levels of 16S rRNA gene sequence similarity between strain NH21 and
the type strains of other member of the clade were 98.6 % with Streptomyces
paucisporeus 1413T, 97.8 % with Streptomyces staurosporininus BK179T and
Streptomyces cocklensis BK168T, a values that correspond to 20, 30 and 31 nt
differences over 1406 and 1393 locations, respectively (Fig. 1).
Fig. 1 Neighbour-joining tree based on nearly complete 16S rRNA gene sequences (1403–1485
nucleotides) showing relationship between strain NH21 and the type strains of Streptomyces species.
Asteriks indicate branches of the tree that were also found using maximum-likelihood and maximum-
parsimony tree making algorithms. Numbers at the nodes indicate the percentage bootstrap values based
on 1000 re-sampled datasets. Only values above 50 % are given. T type strain. Bar 0.005 substitutions per
nucleotide position. The root position of the tree was determined by using Streptacidiphilus
hamsterleyensis DSM 45900T
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Fig. 2 UV–Vis spectrum of silver nanoparticles from supernatant (a), of silver nanoparticles from
biomass (b) and of gold nanoparticles (c). A experimental, B control
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Characterization of Silver and Gold Nanoparticles
After incubation time the color change of test samples were noticed when compared
with controls. Flasks containing silver nanoparticles changed color from yellow to
dark brown/herbal, while containing gold nanoparticles changed color from yellow
to purple. In turn to biomass, the presence of AuNPs was only recorded in culture
supernatant.
UV–Vis Spectrophotometer Analysis
Presence of metal nanoparticles was confirmed using UV–Vis spectrophotometer
(Fig. 2). Silver nanoparticles shown a peak at wavelength of 404, 424 nm and gold
nanoparticles of 564 nm. Observation of peaks by UV–Vis spectrophotometer
analysis is well documented for various metal nanoparticles with a size ranging
from 2 to 100 nm.
TEM Analysis
Each of synthesized metal nanoparticles was analyzed by TEM which revealed
presence of spherical and oval silver nanoparticles, and sizes 44 nm (±9) for
supernatant and 8.4 nm (±12) for biomass synthesized particles. The gold
nanoparticle were mostly spherical in shape and 10 nm (±14) in size (Fig. 3).
The selected area electron diffraction (SAED) analysis revealed that the distances
between atomic planes, calculated from FFT, were 0.232 for supernatant AgNPs,
0.234 nm for biomass obtained AgNPs nm, and 0.204 nm for AuNPs, which are
characteristic for metallic silver and gold nanoparticles (Fig. 3).
The EDX analysis and mapping of elements revealed strong signal of Ag and Au
with high weight percentage of both metals in analyzed samples. The wt% mass of
Ag was recorded at 82.8 and 98.2 % for supernantant and biomass synthesized
AgNPs, respectively. The wt% mass of Au in AuNPs was found to be 84.8 %. The
lowest signal from C and O were also noted (Fig. 4).
Fig. 3 Transmision electron microscopy (TEM) micrograph and SAED pattern of silver nanoparticles
from supernatant (a), of silver nanoparticles from biomass (b) and of gold nanoparticles (c)
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X-Ray Diffraction (XRD) Analysis
The typical XRD patterns of silver and gold nanoparticles biosynthesized from
NH28 actinobacterial strain were observed (Fig. 5a–c). Results confirmed that silver
and gold bionanoparticles were in form of nanocrystals. The characteristic
diffraction peaks for AgNPs formed in supernatant were found at 2h = 38.1,
44.6, 64.6, 77.5, 81.5 and 115.0 (Fig. 5a), and in biomass were present at
2h = 38.1, 44.5, 64.6, 77.6 and 81.7 (Fig. 5b). The typical peaks of AuNPs
were located at 2h = 38.1, 44.3, 64.6, 77.6, 81.7, 98.2, 111.0 and 115.2
(Fig. 5c).
Fig. 4 EDX spectra of a biosynthesized silver nanoparticles from supernatant (a), of silver nanoparticles
from biomass (b) and of gold nanoparticles (c) wt% mass percentage of analyzed element
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Fig. 5 X-ray analysis diffraction (XRD) pattern of silver nanoparticles from supernatant (a), of silver
nanoparticles from biomass (b) and of gold nanoparticles (c)
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FT-IR Spectroscopy Analysis
FTIR analysis of synthesized silver nanoparticles using of filtrate biomass after
starvation, revealed presence of seven bands (3447, 2927, 1658, 1591, 1384, 1034
and 875 cm-1), and from cell free culture presented peaks at 3447, 2925, 1611,
1444, 1384, 1038 and 875 cm-1. Gold nanoparticles analysis showed a bands at
3446, 2926, 1608, 1384, 1041 and 875 cm-1 (Fig. 6).
NTA Analysis
The average size of synthesized silver and gold nanoparticles was 51 nm (±46 nm)
for supernatant synthesized, 27 nm (±25 nm) for biomass and 34 nm (±21 nm) for
gold nanoparticles. The concentration of silver and gold nanoparticles were of
0.18 9 108, 0.31 9 108 and 0.22 9 108 particles per mL, respectively (Fig. 7).
Zeta Potential Analysis
The zeta potentials of AgNPs and AuNPs were noticed to be -9.95 mV, -19.4 mV
and -14.5 mV, respectively. Results indicated monodispersity and stability of the
synthesized nanoparticles due to the electrostatic repulsion between particles in the
solution (Fig. 8).
Minimum Inhibitory and Minimum Bactericidal Concentration Assay
Results of MIC and MBC silver nanoparticles synthesized from supernatant and
biomass of NH21 strain can be seen in Table 1. The activity of nanoparticles (both
Fig. 6 FT-IR spectrum analysis of silver nanoparticles from supernatant (a), of silver nanoparticles from
biomass (b) and of gold nanoparticles (c), control (d)
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Fig. 7 NTA analysis of silver nanoparticles from supernatant (a), of silver nanoparticles from biomass
(b) and of gold nanoparticles (c)
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AgNPs and AuNPs) obtained from culture supernatant against clinical pathogens
was not noticed. Silver nanoparticles obtained from cell filtrate of starved biomass
were effective against clinical bacteria. The MIC values of AgNPs against E. coli
was found to be 2.5 lg/mL, against K. pneumoniae, P. mirabilis and S. infantis
5 lg/mL and agianst P. aeruginosa and B. subtilis 10 lg/mL. Minimum bactericidal
concentrations (MBC) have been demonstrated for two clinical strains—P.
aeruginosa and B. subtilis in concentrations of 140 and 170 lg/mL, respectively.
AFM Analysis
AFM images of B. subtilis, E. coli and P. aeruginosa cells before and after
nanoparticles exposure are shown in Fig. 9. The samples treated with AgNPs for
Fig. 8 Zeta potential distribution of silver nanoparticles from supernatant (a), of silver nanoparticles
from biomass (b) and of gold nanoparticles (c)
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Table 1 Minimum inhibitory and bactericidal concentrations (lg/mL) of AgNPs biosynthesized from
Streptomyces sp. NH21 strain against various bacterial strains
Tested microorganism Survivability % ± (SD)
MIC MBC
2.5 5 10 140 170
Bacillus subtilis ATTC 6633 – – 97 ± 2.2a – 7 ± 0.40
Staphylococcus aureus ATTC 6338 – 99 ± 0.68n.s. – – –
Klebsiella pneumoniae ATTC 700603 – 98 ± 0.91n.s. – – –
Pseudomonas aeruginosa ATTC 10145 – – 81 ± 1.2b 5 ± 0.43 –
Escherichia coli ATTC 8739 98 ± 0.52 – – – –
Proteus mirabilis – 99 ± 0.54n.s. – – –
Salmonella infantis – 94 ± 0.11n.s. – – –
The data is presented as the mean value of three replicates (±SD). Within each column means followed
by different letter(s) are significantly different (P\ 0.05)
n.s. not significant (P[ 0.05), – MIC/MBC not found
Fig. 9 Atomic force microscopy (AFM) analysis of bacteria after treatment with AgNPs (b, e, h); or
AuNPs (c, f, i). Control samples of B. subtilis, E. coli, P. aeruginosa (a, d, g), respectively
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24 h showed differences in morphology compared with controls (Fig. 9b, e, h). The
E. coli appearing more spherical than rod-like shape. Treated cells had a much
rougher surface texture than untreated cells. A destruction of the cell wall,
accompanying with spread out of peptidoglycan or outer membrane fragments on
the gelatin surface, indicating lysis of the cells. The AuNPs treated bacteria (Fig. 9c,
f, i) showed a lack of visible changes.
Discussion
Although more than 10,000 microbial active metabolites have been reported to be
produced by actinomycetes [37] only few genera such as Thermomonospora,
Rhodococcus and Streptomyces have been involved in nanoparticles biosynthesis
[38, 39]. Biogenic synthesis of silver nanoparticles has been well proved by using
bacteria, fungi algae and plants [40–42]. Although in recent years functionalized
gold nanoparticles have attached much attention their application in biomedicine is
still in initial stage.
In the present study, it was found that, Streptomyces sp. strain NH21 have ability
to synthesize silver and gold nanoparticles. Moreover, silver nanoparticles were
synthesized by culture supernatant and filtrate of starved biomass, which were
confirmed in visual observation of color changing from yellow to dark brown. The
synthesis of gold nanoparticles was recorded only in supernatant of Streptomyces sp.
NH21 strain culture when color of solution changed to purple. The changes in color
were observed due to the surface plasmon resonances (SPRs) effect [43, 44] and
reduction of AgNO3 or HAuCl4, respectively. The successful synthesis of silver
nanoparticles by actinobacteria using culture supernatant and filtrate of starved
biomass was confirmed by other authors [45, 46]. Similarly, the actinobacteria
mediated synthesis of gold nanoparticles, in few reports, was noticed either in
culture supernatant or filtrate of starved biomass [47–49]. The UV–Vis spectra of
synthesized nanoparticles showed peaks at 430 and 560 nm, which is specific for
silver and gold nanoparticles, respectively [50, 51]. The absorption peak is related to
particle size, which indicates the formation of Ag and Au nanoparticles [43, 44].
Metal nanoparticles have free electrons, which give to SPR absorption band, due to
the combined vibration of electrons of metal nanoparticles in resonance with the
light wave [52]. Further characterization of nanoparticles was carried out by FTIR
to find out the biomolecules responsible for the formation and stabilization of the
AgNPs and AuNPs. These molecules can bind to nanoparticles through free amine
groups in the proteins [10, 53]. FTIR peaks at 3445 cm-1 can be interpreted as
broad O–H stretching, those between 2920 and 2930 cm-1 are probably of C–H
stretching vibration, and at 1658 cm-1 can be assigned to C=C. The peak at
1591 cm-1 can marked as C=N stretching vibrations of aromatic amines and prove
presence of protein, as well. The absorbance band at 1384 cm-1 is characteristic for
amine and amino-methyl stretching groups [54, 55]. The peak at 1038 cm-1 can be
assigned to C–O stretching vibration, at 875 cm-1 to CH3—groups due CH2 rocking
vibration. Many researchers have proved the presence of proteins over the metal
nanoparticles, that work as a capping agents and are responsible for stabilization of
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nanoparticles [55, 56]. Biosynthesis of gold nanoparticles by Streptomyces isolated
from Himalayan Mountain was undertaken for the first time by Balagurunathan
et al. [47]. Out of ten actinomycete strains studied, four strains showed intracellular
biosynthesis of gold nanoparticles among which Streptomyces viridogens strain
HM10 showed high potency. Spherical and rod shaped gold nanoparticles was
determinate by TEM and X-ray diffraction analysis. The average particle size was
observed in the range of 18–20 nm. The gold nanoparticles were synthesized both
intra—and extracellularly [47].
Zeta potential analysis brought information about stability of synthetized
nanostructures. It was reported that zeta potential value closer to -30 mV indicate
that metal nanoparticles are more stable [40, 57]. The analyses of all tested metal
nanoparticles revealed the negative values of zeta potential. However it is assumed
that synthesized nanoparticles were moderately stable. The negatively charged
nanoparticles were found in work by Fayaz et al. [58] and Kupryashina et al. [14].
The authors reported negative zeta potential values of synthesized nanoparticles of
-8.5 and -5.08 mV, respectively. Mohanta et al. [59] showed that zeta potential of
silver nanoparticles synthesized by Streptomyces sp. was found to be
-17.7 ± 5.3 mV. The difference in zeta potential values of metal nanoparticles,
including silver and gold NPs, previously reported by authors may be connected
with different conditions of synthesis process and differences between bacteria
isolates [14, 57–59].
The NTA and Brownian motion are very fast methods, which allow for
estimation of the particle size, size distribution and concentration of nanoparticles.
Moreover, these methods are more sensitive than dynamic light scattering (DLS)
[2]. Parallel method was also used by Raheman et al. [60] to determine size and size
distribution. In the present study, the average size of silver and gold nanoparticles
was found to be 45 and 10 nm, respectively. The morphology (shape and size) of
synthesized nanoparticles were confirmed by TEM analyses, which revealed that
silver and gold nanoparticles were monodispersed and mostly spherical in shape.
The size of metal nanoparticles obtained by TEM analysis was consistent with those
from NTA. The small sized gold nanoparticles (10–30 nm) from Streptomyces
viridogens was reported by Balagurunathan et al. [47] and silver nanoparticles
(10–40 nm) from S. rocheii by Deepa et al. [61].
Microbial synthesis of nanoparticles with different size and shapes depends on
the organism involved, concentration of metal ions and duration of metal
incubation. For example actinomycete Rhodococcus sp. synthesized gold nanopar-
ticles intracellularly with 5–15 nm size, whereas another actinomycete Ther-
momonospora sp. synthesized gold nanoparticles extracellularly with 8 nm size
[12, 38].
Zoonoz et al. [48] studied biosynthesis of gold nanoparticles in supernatant of
Streptomyces sp. and optimization of synthesis process for enhanced production. To
increase nanoparticle synthesis rate the medium optimization was carried out by
using different physiochemical conditions such as temperature and incubation time
as well as concentration of HAuCl4 used and pH of medium. Out of set of
incubation temperatures used for nanoparticle synthesis, at 30 C the highest
production of silver nanoparticles was noted. Authors also reported that the highest
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production of gold nanoparticles was observed after 96 h of incubation, after
treatment with 3 mM HAuCl4 and at pH 6. TEM micrographs showed the average
particle size ranged from 10 to 30 nm at optimized conditions and were spherical in
shape. Small sized particles can interact with themselves and form larger particles at
nano or micro scale size [48].
There are few reports on gold nanoparticles synthesis by Streptomyces sp. with
antibacterial activity. Balagurunathan et al. [47] showed good antibacterial activity
of gold nanoparticles against S. aureus and E. coli, both approximately 20 mm zone
of inhibition. The antibacterial activity of gold nanoparticles against Gram-positive
and Gram-negative bacteria has been reported also by Ramamurthy et al. [62] or
Bindhu et al. [63]. Results of those studies presented antibacterial nature of gold
nanoparticles but in our studies AuNPs in opposite to AgNPs did not show any
antibacterial activity. According to many investigators the gold nanoparticles are
mainly know from its potential application in medicine as a drug delivery system or
antiviral agent, than as an antibacterial agent Ramamurthy et al. [62].
The antibacterial activity of silver nanoparticles, including chemically as well as
biosynthesized once have been well confirmed. Selvakumar and co-workers [64]
reported antibacterial potential of silver nanoparticles synthesized from Strepto-
myces rocheii against B. subtilis, E. coli and K. pneumoniae. Similar findings were
noticed by Chauhan et al. [65] who used Streptomyces sp. JAR1 for nanoparticle
synthesis.
In present studies, silver nanoparticles synthesized from starved biomass of
Streptomyces sp. NH21 strain showed higher activity than those from supernatant.
Although the MIC value of AgNPs from starved biomass was observed for all tested
bacterial strains the MBC of biosynthesized AgNPs was found against P.
aeruginosa and B. subtilis. The various sensitivity of bacteria to silver nanoparticles
was observed by other authors [65, 66]. Low MIC values of bioAgNPs from
Nocardiopsis sp. MBRC-1 against bacteria was reported by Manivasagan and co-
workers [44]. However, silver nanoparticles obtained from Streptomyces sp. strain
NH21 was found to have much higher antibacterial activity than those stydied by
Singh and co-workers [67]. Authors reported MIC of AgNPs from Acinetobacter
calcoaceticus in the range of 150–600 lg/mL against human pathogenic bacteria.
Classification of bacteria as Gram-positive and Gram-negative is based upon their
different cell wall structure and composition. Sondi and Salopek-Sondi [18] and Rai
et al. [15] claimed that silver nanoparticles attack Gram-negative bacteria by
anchoring and penetrating the cell wall, and as a consequence lead to structural
changes in the cell membrane causing its increased permeability. Some authors
proposed that the antibacterial mechanism of silver nanoparticles is attributable to
the formation of free radicals induced membrane damage. Moreover, silver ions
released from NPs interact strongly with thiol groups in enzymes and phosphorus-
containing bases. Interaction of AgNPs with DNA may prevent bacterial cell
division and DNA replication leading to cell death [4, 68–70].
An atomic force microscopy (AFM) have been used for silver nanoparticles
characterization or microorganism observations [65, 71] but visualization of
bacterial cells after treatment with biosynthesized nanoparticles by AFM has not
been performed. In our studies AFM imaging clearly displayed that AgNPs from
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Streptomyces sp. NH21 strain caused damage of bacterial cells via change in cell
morphology. In contrast, AuNPs produced from this strain did not cause damage of
bacteria cells.
Activity of nanoparticles on microorganism depends on their size, shape and
concentration.
It was proved that smaller nanoparticles are more active against pathogens than
bigger ones [72–74]. Van Phu et al. [75] synthesized small nanoparticles in range of
4.3–10 nm and found that concentration and size of AgNPs was mainly responsible
for the antibacterial effect along with treatment time. Similar observations were
recorded by Martinez-Gutierez et al. [76].
Biosynthesis of silver and gold nanoparticles from actinobacteria is rapid, cheap
and simple method to obtain nanoparticles in non-toxic and eco-friendly way.
Biosynthesized nanoparticles are small, stable, with antibacterial properties against
bacterial pathogens.
Our studies have added a new microbial source for biosynthesis of silver and gold
nanoparticles. Further studies are required for exploitation of Streptomyces derived
gold nanoparticles and its use in other biotechnological fields.
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